Vildagliptin / Metformin hydrochloride Accord Avrupa Birliği - Litvanyaca - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - cukrinis diabetas, 2 tipas - narkotikai, vartojami diabetu - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ir 5. 1, jei yra duomenų apie skirtingus derinius).

Vildagliptin/Metformin hydrochloride ELVIM Litvanya - Litvanyaca - SMCA (Valstybinė vaistų kontrolės tarnyba)

vildagliptin/metformin hydrochloride elvim

sia elvim - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/850 mg - metformin and vildagliptin

Vildagliptin/Metformin hydrochloride ELVIM Litvanya - Litvanyaca - SMCA (Valstybinė vaistų kontrolės tarnyba)

vildagliptin/metformin hydrochloride elvim

sia elvim - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and vildagliptin

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Avrupa Birliği - Litvanyaca - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ir 5. 1, jei yra duomenų apie skirtingus derinius).

Vildagliptin/Metformin Teva Litvanya - Litvanyaca - SMCA (Valstybinė vaistų kontrolės tarnyba)

vildagliptin/metformin teva

teva b.v. - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/850 mg - metformin and vildagliptin

Vildagliptin/Metformin Teva Litvanya - Litvanyaca - SMCA (Valstybinė vaistų kontrolės tarnyba)

vildagliptin/metformin teva

teva b.v. - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and vildagliptin

Eucreas Avrupa Birliği - Litvanyaca - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Zomarist Avrupa Birliği - Litvanyaca - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - narkotikai, vartojami diabetu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Vilspox Litvanya - Litvanyaca - SMCA (Valstybinė vaistų kontrolės tarnyba)

vilspox

sandoz d.d. - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg; 50 mg/850 mg - metformin and vildagliptin

Vimetso Litvanya - Litvanyaca - SMCA (Valstybinė vaistų kontrolės tarnyba)

vimetso

krka, d.d., novo mesto - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/850 mg - metformin and vildagliptin